Profitelligence Profitelligence · Filing Ledger Open WST research →

Form 8-K · Current Report · Filed 2025-04-24

West Pharmaceutical Services Reports First-Quarter 2025 Results, Increases Guidance, and Declares Dividend

West Pharmaceutical Services, Inc. reported first-quarter 2025 results with net sales of $698.0 million, representing a 0.4% increase. The company announced an increase in its full-year 2025 guidance for net sales and adjusted-diluted EPS. Additionally, the Board of Directors approved a third-quarter 2025 dividend of $0.21 per share, payable on August 6, 2025.

Filer
West Pharmaceutical Services Inc. WST · NYSE
Filed
Accession
0000105770-25-000029
CIK
0000105770
Signal
High impactHealthcare

Items reported

Item 2.02

Results of Operations and Financial Condition

Earnings Beat Raised Guidance General Statement
Item 7.01

Regulation FD Disclosure

Press Release Furnished
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$218.18

Next session

-1.7%

Since filing

+56.3%

Latest close

$340.96

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WST reporting the same item, with the next session's move:

Exhibits (2)

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another WST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts